Geoff von Maltzahn, PhD is the Co-Founder and CEO of Lila Sciences, the world’s first scientific superintelligence platform and autonomous lab for life, chemistry, and materials science. He is among the most successful scientific entrepreneurs of his generation. Listed as an inventor on over 200 patents and pending applications, his technologies underpin more than 10 companies integrating biology and AI to transform human health and sustainability. Geoff’s groundbreaking companies have achieved over $10b in public and private market capitalization and include Generate:Biomedicines, Quotient Therapeutics, Tessera Therapeutics, Indigo Agriculture, Sana Biotechnology (NASDAQ: SANA), and Seres Therapeutics (NASDAQ: MCRB). Geoff was awarded a PhD from MIT; an MS in bioengineering from the University of California, San Diego; and an SB in chemical engineering from MIT.